Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
Part of paid clinical trials in Chapel Hill, North Carolina.
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Study ID
- NCT01000883
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- biologic sample preservation procedure — OTHERapproximately 16-20 milligrams of tumor tissue per core will be obtained for research purposes.
- laboratory biomarker analysis — OTHEREvaluation of biomarkers will occur as questions are asked in subsequent correlative studies.
- biopsy — PROCEDUREcancer tissue will be taken from the primary breast cancer site as well as the metastatic tumor sites. Two tubes of whole blood will also be collected.
Study Details
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at tissue and blood samples from women with locally advanced or metastatic breast cancer
Key Dates
- Start date
- Dec 1, 1998
- Status verified
- Jun 2025
- Primary completion
- Nov 30, 2030
- Completion
- Nov 30, 2032
Study Design
- Enrollment
- 10,000 participants (estimated)
Primary Outcome Measure
Generation of a biorepository for current and future correlative research studies [ Time Frame: Diagnosis, between treatments,7-14 days after start of treatment and at time of definitive therapy ]
Central Contacts
- Adrianna Warner(919) 966-7847
- Erin Kelly(919) 966-0040
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill | Chapel Hill | North Carolina | 27599-7295 | Clinical Trials Office - Lineberger Comprehensive Cancer Cente 877-668-0683 |
Find similar trials in Chapel Hill, NC
By condition
By specialty
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerPHASE3 · Recruiting · Canadian Cancer Trials Group · Fairbanks, Alaska